Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Healthy Clinical Trial

Official title:

Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01022931
• Other study ID #: H1N1epidemiology
• Status: Completed
• Phase: N/A
• First received: November 30, 2009
• Last updated: December 10, 2012
• Start date: October 2009
• Est. completion date: July 2012

Study information

• Verified date: December 2012
• Source: University Hospital, Geneva
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Laws and standards
• Study type: Observational

Clinical Trial Summary

This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: July 2012
• Est. primary completion date: February 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 16 Years

Eligibility

Inclusion Criteria:

• suspicion of H1N1 infection

Exclusion Criteria:

• Not available for a 30 days follow-up

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Asthmatic
• Healthy
• Immunosuppressed
• Neuromuscular Diseases

Locations

Country	Name	City	State
Switzerland	Children's Hospital of Geneva, HUG	Geneva	GE

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ABCB1 polymorphisms	ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia	6 months	No